These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11096229)

  • 41. Longitudinal comparison of HIV-1 RNA burden in plasma and cerebrospinal fluid in two patients starting triple combination antiretroviral therapy.
    Iftimovici E; Rabian C; Burgard M; Peytavin G; Rouzioux C; Viard JP
    AIDS; 1998 Mar; 12(5):535-7. PubMed ID: 9543456
    [No Abstract]   [Full Text] [Related]  

  • 42. Overcoming obstacles to the success of protease inhibitors in highly active antiretroviral therapy regimens.
    Moyle G
    AIDS Patient Care STDS; 2002 Dec; 16(12):585-97. PubMed ID: 12542932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute ischemic stroke lasting for 5 days without definite lesions on diffusion-weighted magnetic resonance imaging in a patient with severe leukoaraiosis.
    Han SJ; Kim BS; Shon YM; Cho AH
    J Stroke Cerebrovasc Dis; 2011; 20(5):482-4. PubMed ID: 20444627
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stereological analysis of cerebral atrophy in human immunodeficiency virus-associated dementia.
    Subbiah P; Mouton P; Fedor H; McArthur JC; Glass JD
    J Neuropathol Exp Neurol; 1996 Oct; 55(10):1032-7. PubMed ID: 8858000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiretroviral protease inhibitor therapy leads to hyperglycaemia, hyperlipidaemia and lipodystrophy.
    Sangraula H; Sharma KK; Dwivedi S
    Natl Med J India; 2001; 14(6):347-8. PubMed ID: 11804366
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of permanent middle cerebral artery occlusion on Cytoglobin expression in the mouse brain.
    Raida Z; Reimets R; Hay-Schmidt A; Hundahl CA
    Biochem Biophys Res Commun; 2012 Jul; 424(2):274-8. PubMed ID: 22750003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Progression of HIV-associated dementia treated with HAART.
    Dougherty RH; Skolasky RL; McArthur JC
    AIDS Read; 2002 Feb; 12(2):69-74. PubMed ID: 11905143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hemodynamic effect of external counterpulsation is a different measure of impaired cerebral autoregulation from vasoreactivity to breath-holding.
    Lin W; Xiong L; Han J; Leung T; Leung H; Chen X; Wong KS
    Eur J Neurol; 2014 Feb; 21(2):326-31. PubMed ID: 24313861
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tandem internal carotid artery/middle cerebral artery occlusion: an independent predictor of poor outcome after systemic thrombolysis.
    Rubiera M; Ribo M; Delgado-Mederos R; Santamarina E; Delgado P; Montaner J; Alvarez-Sabín J; Molina CA
    Stroke; 2006 Sep; 37(9):2301-5. PubMed ID: 16888266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Younger Stroke Patients With Large Pretreatment Diffusion-Weighted Imaging Lesions May Benefit From Endovascular Treatment.
    Gilgen MD; Klimek D; Liesirova KT; Meisterernst J; Klinger-Gratz PP; Schroth G; Mordasini P; Hsieh K; Slotboom J; Heldner MR; Broeg-Morvay A; Mono ML; Fischer U; Mattle HP; Arnold M; Gralla J; El-Koussy M; Jung S
    Stroke; 2015 Sep; 46(9):2510-6. PubMed ID: 26251252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protease-activated receptor 2 and bradykinin-mediated vasodilation in the cerebral arteries of stroke-prone rats.
    Smeda JS; McGuire JJ; Daneshtalab N
    Peptides; 2010 Feb; 31(2):227-37. PubMed ID: 19954757
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disappearance of the hyperdense MCA sign after stroke thrombolysis: implications for prognosis and early patient selection for clot retrieval.
    Elofuke P; Reid JM; Rana A; Macleod MJ
    J R Coll Physicians Edinb; 2016 Jun; 46(2):81-86. PubMed ID: 27929569
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Foscarnet activity on human immunodeficiency virus type 1 in the central nervous system.
    Delforge ML; Farber CM; De Leener F; Caroyer JM; Liesnard C; Van Vooren JP
    Clin Infect Dis; 1999 Apr; 28(4):931. PubMed ID: 10825078
    [No Abstract]   [Full Text] [Related]  

  • 54. Drug treatment for HIV-1-associated dementia.
    von Giesen HJ; Arendt G
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1643-6. PubMed ID: 12476967
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anergic disseminated toxoplasmosis in a patient with the acquired immunodeficiency syndrome.
    Artigas J; Grosse G; Niedobitek F
    Arch Pathol Lab Med; 1993 May; 117(5):540-1. PubMed ID: 8489347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions].
    Valikovics A
    Ideggyogy Sz; 2007 Jul; 60(7-8):301-10. PubMed ID: 17713111
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term cardiovascular risk with protease inhibitors and management of the dyslipidemia.
    Kannel WB; Giordano M
    Am J Cardiol; 2004 Oct; 94(7):901-6. PubMed ID: 15464673
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell death mechanisms in HIV-associated dementia: the involvement of syncytia.
    Nardacci R; Antinori A; Kroemer G; Piacentini M
    Cell Death Differ; 2005 Aug; 12 Suppl 1():855-8. PubMed ID: 15846379
    [No Abstract]   [Full Text] [Related]  

  • 59. Risperidone for the treatment of delusional disorder due to HIV disease.
    Maha A; Goetz K
    J Neuropsychiatry Clin Neurosci; 1998; 10(1):111. PubMed ID: 9547476
    [No Abstract]   [Full Text] [Related]  

  • 60. Successful zidovudine (AZT) treatment in a case of human immunodeficiency virus (HIV)-1-associated dementia complex.
    Sobanski T; Assion HJ; Scholl HP; Höflich G; Laux G
    Biol Psychiatry; 1996 Jun; 39(12):1065-6. PubMed ID: 8780847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.